CEREBRO-X

Parameter	Value	Method
ΔG single ligand	-12.50 kcal/mol	LIE approximation
ΔG avidity	-10.09 kcal/mol	Bell cooperative binding
Receptors engaged	50	Geometric model
Kd class	Moderate (10-100nM)	Equilibrium binding

Capability Dimension	Score	Modules Active
BBB Engineering	100%	✅
PK Prediction	95%	✅
Safety Screening	90%	✅
Manufacturing	85%	✅
Regulatory (FDA)	90%	✅
Clinical Translation	80%	✅
IP & Economics	85%	✅
Stability	90%	✅

Severity	Problem Identified	Evidence	DDS Solution	Expected Outcome
HIGH	Cardiac off-target risk (hERG/Nav/Cav channels)	QSAR panel: cardiac receptor score > safety threshold	CNS-targeted plga reduces systemic expos	CNS bioavailability 53.0% with reduced c

Step	Setting
Freezing	-50°C @ 1°C/min
Primary drying	-32°C, 0.148 mbar
Secondary drying	+25°C, 0.05 mbar
Tg' safety margin	-2.0°C above Tg'
Cake collapse risk	OK: primary drying fixed at Tg

🧬 All 62 Principles — Unified Scoreboard (Top-1 DDS)

For Donepezil, the Top-1 DDS achieved a composite score of 80.5/100 (EXCELLENT). Below are the CNS group rollups followed by the FULL 62-principle scoreboard covering all three pipeline classes: A (Surrogate) B (Deep) C (Translational)

CNS Principle Group Rollups

G1 CNS Delivery: 87.1/100

G2 Release Kinetics: 54.4/100

G3 Stability: 76.5/100

G4 Safety: 85.5/100

G5 Glymphatic BBB: 61.7/100

G6 Manufacturability: 77.8/100

G7 DrugDDS Fit: 61.5/100

G8 Translational: 0.0/100

All 62 Principles (P01 → P62)

P#	Class	Title	Score	Conf.	Method
P01	B	Adversarial Stress-Testing Engine	62.4	MODERATE	Mean of 6 stress scenarios (pH4.5, pH2, pH8.5, 42°C, complement, oxidation); each sce
P02	B	Cross-Species PK Scaling (Allometric)	100.0	MODERATE	BW^0.75 scaling + class-specific adjustment
P03	A	Competitive DDS Landscape Radar	81.8	LOW	Novelty = 100 - frequency_of_combo_in_CNS_trials, modified by whether the drug's LogP
P04	B	Quantum Coherence Transport Model	0.7	MODERATE	WKB tunneling: P ∝ exp(-2·barrier)
P05	A	In-Silico Patient Subgroup Stratifier	50.0	MODERATE	% subgroups responding (lower CYP risk = more universal)
P06	A	Lysosomal Trafficking Predictor	77.5	MODERATE	Carrier endosomal_escape ⊕ drug-passive permeation at pH 5.5; drug-passive = LogP-dri
P07	A	Real-Time Literature Mining (PubMed)	100.0	LOW	log-count proxy of literature support
P08	B	Degradation Kinetics Under Oxidative Stress	57.3	MODERATE	Arrhenius k=A·exp(-Ea/RT) for carrier; minus penalties for drug-side oxidation-prone
P09	A	Digital Pharmacovigilance Engine	100.0	MODERATE	100 - sum(metabolite organ accumulation risks)
P10	B	LNP Ionization State Predictor	60.0	LOW	Non-LNP carrier — falls back to drug-side ionization stability at storage pH 7.4 (low
P11	B	Formulation Instability Fingerprint	90.0	MODERATE	100 - sum(weak-bond penalties from SMILES)
P12	B	CNS Disease-Stage-Aware Dosing	78.8	MODERATE	Score = 100·BBB_integrity_factor × (0.4 + 0.6·CNS-MPO/6) + targeting_boost (larger bo
P13	B	PBPK Digital Twin	100.0	MODERATE	AUC_brain/AUC_plasma proxy; 3-compartment surrogate
P14	A	In-silico Dissolution & Release Profile	82.6	MODERATE	t50 from carrier kinetics × drug-membrane partition factor (10^logK_mem); HBD-anchori
P15	A	Shelf-life & Degradation Predictor	92.5	MODERATE	Arrhenius baseline × (0.7 + 0.3·EE) × drug_hydrolysis_factor (0.08 penalty per hydrol
P16	B	Scale-up & Manufacturability	45.7	MODERATE	Scale-readiness × shear-robustness, minus drug-processability penalties (MW, HBD-crys
P17	A	Nanotoxicity & Immunogenicity Screening	86.2	MODERATE	Mean of (hemolysis penalized by drug net+ charge, complement penalized for biologics,
P18	B	Active Targeting & Receptor Binding	87.2	HIGH	Ligand-affinity table × density × drug-compatibility (receptor-pathway-specific drug
P19	A	QbD - Quality by Design Engine	100.0	MODERATE	Fraction of CQAs (size, zeta, EE, PDI, drug-loading) within ICH spec — 5th CQA depend
P20	A	Cost-Efficiency Engine	57.4	LOW	Score = 100 - 3·($/mg estimate, drug+carrier+ligand+API). Drug API cost from stereoce
P21	C	Pre-IND Regulatory Reports	0.0	—	skipped_deep_validation_insufficient
P22	A	Protein Corona Predictor	61.5	MODERATE	100 × exp(-corona_thickness/10); thickness from carrier (\|zeta\|, size) + drug-side (L
P23	B	Dynamic Crystal Polymorphism	77.0	MODERATE	100 - polymorph risk (rot_bonds + H-bond pattern)
P24	B	Shear-Stress & Scale-Up Collapse	89.3	MODERATE	log10(crit_shear/operating_shear) × 30; crit_shear softened by drug-load for lipid ca
P25	A	Extractables & Leachables	80.0	MODERATE	100 - leachables risk by drug LogP × carrier
P26	A	Microbiome-Excipient Interactions	81.1	MODERATE	100 - mean_microbiome_degradability(carrier) - drug-side risk (anionic-fraction, pola
P27	A	Lyophilization Cycle Optimizer	77.5	MODERATE	100 - (\|Tg'\| - 5) × 1.5
P28	A	3D-Printed Polypill Rheology	80.0	MODERATE	Carrier-specific printability index
P29	B	Biomimetic & Exosome Engineering	55.0	MODERATE	Stealth-from-macrophage score; PEG ≥5% boost
P30	B	QM/MM Stimuli-Responsive Cleavage	45.0	MODERATE	Score = 50 × \|7.4 - pH_trigger\|
P31	B	In-Silico Biodistribution	100.0	MODERATE	brain% = BBB · ligand · size_match · 100; 100 if ≥5%
P32	C	Automated FTO & IP Evader	0.0	—	skipped_deep_validation_insufficient
P33	B	BBB Quantum Breaker (Trojan-Horse Design)	56.4	MODERATE	(0.6·ligand + 0.4·size) × density_factor
P34	A	DNA Logic Gates & Bio-computing	20.0	MODERATE	DNA-based carriers score high
P35	A	Microgravity Formulation Engine	100.0	LOW	Sedimentation-Péclet proxy; smaller = better
P36	A	Geopolitical Supply-Chain Resilience	60.0	MODERATE	Supplier-diversity index by carrier + ligand
P37	A	Eco-Destructible Pharma	95.0	MODERATE	Biodegradability index by carrier class
P38	B	Glymphatic Clearance Trap	100.0	MODERATE	Stokes-Einstein: optimum 80-150 nm
P39	A	Microglial Activation & Neuroinflammation	100.0	MODERATE	100 - (cationic_charge + carrier_risk - PEG_protection)
P40	B	Intranasal-to-Brain Delivery	65.0	MODERATE	Mucoadhesion + thermo-responsive boost
P41	B	Exosome Cargo Loading Thermodynamics	40.0	LOW	Not an exosome carrier — N/A
P42	A	Region-Specific Spatiotemporal Navigation	85.0	MODERATE	Ligand-region specificity table
P43	B	FUS-Responsive Nanocarriers	20.0	MODERATE	FUS-response by carrier acoustic properties
P44	B	CNS-Specific PBPK Time-Machine	100.0	MODERATE	AUC over 24h therapeutic window proxy
P45	C	FDA 21 CFR Part 11 Compliance	0.0	—	skipped_deep_validation_insufficient
P46	A	Polypharmacy & DDI Simulator	100.0	MODERATE	CYP-inhibition heuristic from SMILES
P47	B	Free Energy Perturbation (FEP+)	90.0	LOW	Vina-like ΔG proxy from MW + LogP (deep mode runs full FEP+)
P48	A	Off-Target Toxicity & QSAR (50-receptor)	55.0	MODERATE	50-receptor QSAR surrogate (hERG, 5HT2B, AhR risks)
P49	A	Organ-on-a-Chip Simulator	80.0	MODERATE	Microfluidic compatibility (size + PDI)
P50	B	Cryo-Chain Thermal Excursion Predictor	71.5	MODERATE	Distance from -20°C phase transition × 1.3
P51	B	Terminal Sterilization Survivability	85.0	MODERATE	Carrier gamma-radiation survival (25 kGy)
P52	A	Continuous Manufacturing Digital Twin	80.0	MODERATE	Continuous-process readiness by carrier
P53	A	Dark Data & Negative Results Vault	100.0	MODERATE	Similarity-to-documented-failure
P54	A	Pharmacogenomic-Guided Targeting	70.0	MODERATE	Class-based pharmacogenomic applicability
P55	C	Automated Grant & NIH Proposal Generator	0.0	—	skipped_deep_validation_insufficient
P56	C	Patentability Score Engine	0.0	—	skipped_deep_validation_insufficient
P57	B	Microfluidics & LNP Synthesis Digital Twin	90.0	MODERATE	Microfluidic readiness for size 50-150 nm
P58	B	Impurity Cascade Predictor	85.0	MODERATE	Carrier residual-metals impurity profile
P59	B	4D Shape-Shifting Carriers	30.0	MODERATE	Stimuli-responsive bonus by release kinetics
P60	A	Swarm Nanorobotics Intelligence	15.0	LOW	Swarm capability (most carriers: no)
P61	B	Synthetic Clinical Trials & Virtual Humans	95.0	MODERATE	Virtual-cohort responder fraction
P62	A	Biobetter / Supergeneric Generator	50.0	LOW	Novelty distance from on-market CNS DDS

RVG29-PLGA-NP: composite CNS-principle score = 80.5/100 (EXCELLENT). Carrier: plga, size 0.0 nm, ζ +0.0 mV, ligand: RVG29. Strongest group: G1 CNS Delivery (87.1/100); weakest: G8 Translational (0.0/100). Evaluated against all 57 Class A surrogate principles.

🔬 H28 — Class B Deep Physics Validation (Top-1 DDS)

Verdict: MARGINAL | 19/28 principles validated (67.9% — threshold 70%)

Combined score (surrogate pass-through + real physics): 19/28 principles scored PASSED (67.9%). Of these, only 7/28 principles ran independent deep computation (passed 7/7 = 100.0%); the rest re-used their Class-A surrogate score pending a future full-physics HPC run. Cite independent_pct, not pct, as evidence of physics-based validation.

Principle	Validated	Score	Value	Confidence	Method	Narrative
P01	✅	62.4	62.41	MODERATE	Full MD stress simulation — surrogate value confirmed (full-physics HPC deferred)	Full MD stress simulation: surrogate score 62.41 PASSED. Full deep simulation requires external HPC.
P02	✅	70.0	54.28	MODERATE	Resolved clinical half-life (bundle tier 6); Mahmood 2007 exponents shown for reference only (half-l	Clinical t½ = 54.3h (population regression / class estimate, bundle tier 6). Reference allometric exponents (Mahmood 2007) for a genuine ani
P04	❌	0.7	0.0037	LOW	Full QM tunneling (QCElemental + ASE) — surrogate value confirmed (full-physics HPC deferred)	Full QM tunneling (QCElemental + ASE): surrogate score 0.74 NEEDS REVIEW. Full deep simulation requires external HPC.
P08	❌	57.3	57.3	LOW	Full radical-chain reaction MD — surrogate value confirmed (full-physics HPC deferred)	Full radical-chain reaction MD: surrogate score 57.3 NEEDS REVIEW. Full deep simulation requires external HPC.
P10	✅	60.0	60.0	MODERATE	Constant-pH MD simulation — surrogate value confirmed (full-physics HPC deferred)	Constant-pH MD simulation: surrogate score 60.0 PASSED. Full deep simulation requires external HPC.
P11	✅	90.0	90	MODERATE	DFT bond dissociation energies — surrogate value confirmed (full-physics HPC deferred)	DFT bond dissociation energies: surrogate score 90 PASSED. Full deep simulation requires external HPC.
P12	✅	78.8	78.75	MODERATE	Stage-specific PBPK with full BBB physiology — surrogate value confirmed (full-physics HPC deferred)	Stage-specific PBPK with full BBB physiology: surrogate score 78.75 PASSED. Full deep simulation requires external HPC.
P13	✅	100.0	12.6473	HIGH	3-compartment PBPK ODE (scipy.integrate.odeint): blood ⇌ brain ⇌ peripheral, 24h time course. k_bb_i	Brain AUC = 1813.87 units·h, plasma AUC = 143.42 units·h, ratio = 12.6473. Cmax_brain = 78.74 at t = 8.7h. PASSED AUC ratio.
P16	❌	45.7	45.72	LOW	CFD of 1000L bioreactor — surrogate value confirmed (full-physics HPC deferred)	CFD of 1000L bioreactor: surrogate score 45.72 NEEDS REVIEW. Full deep simulation requires external HPC.
P18	✅	98.0	-9.8	HIGH	MM/GBSA-style ΔG estimate from validated ligand-receptor Kd database. Full atomistic docking deferre	Ligand 'rvg29' → receptor 'nAChR', ΔG = -9.8 kcal/mol. STRONG BBB-targeting.
P23	✅	77.0	77.0	MODERATE	CSP via DFT — surrogate value confirmed (full-physics HPC deferred)	CSP via DFT: surrogate score 77.0 PASSED. Full deep simulation requires external HPC.
P24	✅	89.3	89.31	MODERATE	Full CFD + MD coupling — surrogate value confirmed (full-physics HPC deferred)	Full CFD + MD coupling: surrogate score 89.31 PASSED. Full deep simulation requires external HPC.
P29	❌	55.0	55	LOW	Full membrane-fusion MD — surrogate value confirmed (full-physics HPC deferred)	Full membrane-fusion MD: surrogate score 55 NEEDS REVIEW. Full deep simulation requires external HPC.
P30	❌	45.0	45.0	LOW	Full QM/MM (PySCF or ORCA) — surrogate value confirmed (full-physics HPC deferred)	Full QM/MM (PySCF or ORCA): surrogate score 45.0 NEEDS REVIEW. Full deep simulation requires external HPC.
P31	✅	100.0	54.05	MODERATE	7-organ whole-body distribution with size + charge + ligand-status modifiers.	Brain uptake = 54.05%, liver = 7.5%, spleen = 3.6%. GOOD CNS DELIVERY.
P33	❌	56.4	56.4	LOW	Atomistic docking + SMD pulling — surrogate value confirmed (full-physics HPC deferred)	Atomistic docking + SMD pulling: surrogate score 56.4 NEEDS REVIEW. Full deep simulation requires external HPC.
P38	✅	95.4	15.6	HIGH	Stokes-Einstein D = k_B·T/(6πηr) at 37°C, η_CSF = 7×10⁻⁴ Pa·s. Brain residence scaled to 50-nm refer	D_CSF = 4.99 µm²/s, brain residence ≈ 15.6h. IDEAL (target 6-48h).
P40	✅	65.0	65	MODERATE	Full nasal cavity CFD — surrogate value confirmed (full-physics HPC deferred)	Full nasal cavity CFD: surrogate score 65 PASSED. Full deep simulation requires external HPC.
P41	❌	40.0	40	LOW	Full membrane mechanics MD — surrogate value confirmed (full-physics HPC deferred)	Full membrane mechanics MD: surrogate score 40 NEEDS REVIEW. Full deep simulation requires external HPC.
P43	❌	20.0	20	LOW	Full acoustic radiation force MD — surrogate value confirmed (full-physics HPC deferred)	Full acoustic radiation force MD: surrogate score 20 NEEDS REVIEW. Full deep simulation requires external HPC.
P44	✅	100.0	47.76	HIGH	4-compartment CNS-PBPK ODE with glymphatic clearance: Blood ⇌ Brain_ECF → CSF → Blood. Stokes-Einste	Therapeutic window = 47.8h (brain ≥ 5% dose). Brain AUC = 1278.0, Cmax = 72.91. PASSED.
P47	✅	84.6	-7.69	HIGH — real AutoDock Vina docking on experimental receptor structure	AutoDock Vina 1.2.7 (real docking)	Predicted ΔG_binding = -7.69 kcal/mol (AutoDock Vina 1.2.7 (real docking)). MODERATE affinity.
P50	✅	71.5	71.5	MODERATE	Full coarse-grained MD lipid phase transition — surrogate value confirmed (full-physics HPC deferred	Full coarse-grained MD lipid phase transition: surrogate score 71.5 PASSED. Full deep simulation requires external HPC.
P51	✅	85.0	85	MODERATE	Full radical-chain damage MD — surrogate value confirmed (full-physics HPC deferred)	Full radical-chain damage MD: surrogate score 85 PASSED. Full deep simulation requires external HPC.
P57	✅	90.0	90	MODERATE	Full CFD of mixer geometry — surrogate value confirmed (full-physics HPC deferred)	Full CFD of mixer geometry: surrogate score 90 PASSED. Full deep simulation requires external HPC.
P58	✅	85.0	85	MODERATE	Full QM/MM cascade simulation — surrogate value confirmed (full-physics HPC deferred)	Full QM/MM cascade simulation: surrogate score 85 PASSED. Full deep simulation requires external HPC.
P59	❌	30.0	30	LOW	Full coarse-grained MD morphological transition — surrogate value confirmed (full-physics HPC deferr	Full coarse-grained MD morphological transition: surrogate score 30 NEEDS REVIEW. Full deep simulation requires external HPC.
P61	✅	95.0	95	MODERATE	Full Monte-Carlo population PBPK — surrogate value confirmed (full-physics HPC deferred)	Full Monte-Carlo population PBPK: surrogate score 95 PASSED. Full deep simulation requires external HPC.

📋 H29 — Class C Translational Deliverables (Top-1 DDS)

Translational outputs for Donepezil's validated Top-1 DDS. These are NOT used for ranking — they are administrative deliverables triggered only AFTER deep physics validation passes.